All data are based on the daily closing price as of December 5, 2025
j

Japan Tobacco

2914.TSE
37.07 USD
-0.17
-0.46%

Overview

Last close
37.07 usd
Market cap
65.82B usd
52 week high
37.92 usd
52 week low
23.39 usd
Target price
35.03 usd

Valuation

P/E
52.6311
Forward P/E
14.9925
Price/Sales
2.9494
Price/Book Value
2.461
Enterprise Value
70.50B usd
EV/Revenue
3.303
EV/EBITDA
17.2403

Key financials

Revenue TTM
22.26B usd
Gross Profit TTM
12.51B usd
EBITDA TTM
6.33B usd
Earnings per Share
0.7 usd
Dividend
1.29 usd
Total assets
57.34B usd
Net debt
5.28B usd

About

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, pharmaceuticals, and processed foods in Japan and internationally. The company operates through three segments: Tobacco Business, Pharmaceutical Business, and Processed Food Business. It offers tobacco products, such as cigarettes, heat-not-burn tobacco products, E-vapor products, fine cut tobacco products, cigars, pipes, smokeless tobacco products, and hookah and kretek products. The company provides reduced-risk products, including infused tobacco capsules and heated tobacco sticks. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, kidney and metabolism, immunity/inflammation, and central nervous system. Further, the company provides frozen and room-temperature products comprising frozen udon noodles, packed rice, and frozen okonomiyaki; and seasonings, including yeast extracts, assembled, kelp and bonito extracts, and oyster sauces. It offers its products under the Winston, Camel, MEVIUS, and LD brands. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.
  • Symbol
    2914.TSE
  • Exchange
    TSE
  • Isin
    JP3726800000
  • Country
    Japan
  • Sector
    Consumer Defensive
  • Industry
    Tobacco
  • CEO
    Mr. Masamichi Terabatake
  • Headquarter
    Tokyo
  • Web site
    https://www.jt.com
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top